Cindy L. O’Bryant
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Lia GoreD. Ross CamidgeLaura Q.M. ChowSami DiabBonnie KyJoAnn LindenfeldDavy ChengRobert L. Page
- Topics
- Cancer Treatment and Pharmacology (10 papers)Colorectal Cancer Treatments and Studies (8 papers)Lung Cancer Treatments and Mutations (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Cindy L. O’Bryant
67 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Molecular Biology 917
- Oncology 738
- Pulmonary and Respiratory Medicine 471
- Cancer Research 220
- Cardiology and Cardiovascular Medicine 205
Countries citing papers authored by Cindy L. O’Bryant
This map shows the geographic impact of Cindy L. O’Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cindy L. O’Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cindy L. O’Bryant more than expected).
Fields of papers citing papers by Cindy L. O’Bryant
This network shows the impact of papers produced by Cindy L. O’Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cindy L. O’Bryant. The network helps show where Cindy L. O’Bryant may publish in the future.
Co-authorship network of co-authors of Cindy L. O’Bryant
This figure shows the co-authorship network connecting the top 25 collaborators of Cindy L. O’Bryant. A scholar is included among the top collaborators of Cindy L. O’Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cindy L. O’Bryant. Cindy L. O’Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 11 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 29 | |
| 8 | 24 | |
| 9 | 1 | |
| 10 | 5 | |
| 11 | 134 | |
| 12 | 52 | |
| 13 | 19 | |
| 14 | 29 | |
| 15 | 23 | |
| 16 | 19 | |
| 17 | 7 | |
| 18 | A phase 1 study of belinostat (PXD101) in combination with bortezomib in patients with advanced solid tumors and lymphoma | 3 |
| 19 | 22 | |
| 20 | 28 |
About Cindy L. O’Bryant
Cindy L. O’Bryant is a scholar working on Geriatrics and Gerontology, Oncology and Transplantation, having authored 68 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Geriatrics and Gerontology (129 citations), Oncology (738 citations) and Family Practice (52 citations). Cindy L. O’Bryant has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lia Gore, D. Ross Camidge, Laura Q.M. Chow, Sami Diab, Bonnie Ky, JoAnn Lindenfeld, Davy Cheng, Robert L. Page, C. Michael Stein and Robin J. Trupp. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.